CHOLINBUTYRATSALZ

European patent · EP3448170 · In force

Register entry

Publication number
EP3448170
Application number
EP17725356
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 25, 2017
Published
Mar 6, 2019
Granted
Mar 16, 2022
Protection ends at the latest
Apr 24, 2037
Next annual fee due
Apr 30, 2027
IPC classes
A23K 20/174 (2016.01)
A61K 31/221 (2006.01)
A61K 31/205 (2006.01)
A23L 33/10 (2016.01)
A23K 20/158 (2016.01)
A23K 20/105 (2016.01)
A61K 31/14 (2006.01)
A61K 31/19 (2006.01)
Priority
BE 1605290 27.04.2016
BE 1605291 27.04.2016
PCT application
PCT/IB2017/052366 25.04.2017
PCT publication
WO2017/187335 02.11.2017
Filing language
Dutch
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Jan 25, 2023

    Change

    Published in Swissreg on 25.01.2023

  6. Mar 16, 2022

    Granted

    Published in Swissreg on 16.03.2022

Parties

Holder

Abergavenny NV

Sint-Pietersvliet 3 Bus 2, 2000 Antwerpen, BE

Inventor

VANDEN AVENNE, Marc

2000 Antwerpen, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.